World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Trial of Stem Cell-derived Therapy for Parkinson’s to Open in Sweden

Trial of Stem Cell-derived Therapy for Parkinson’s to Open in Sweden

by admin | Dec 27, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Margarida Maia, PhD – Parkinson’s News Today A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s disease has been approved by the Swedish Medical Products Agency. The therapy, called STEM-PD,...
Auto Draft

A stress test for blood stem cells

by admin | Dec 23, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Nature Italy By studying how hematopoietic stem cells respond to age and damage, Raffaella di Micco aims to anticipate the long-term effects of some gene therapies. This is a scene from my daily routine in my lab in Milan where we study hematopoietic stem cells,...
Ground-breaking stem cell procedure restores patient’s mobility and joy for life

Ground-breaking stem cell procedure restores patient’s mobility and joy for life

by admin | Dec 22, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By The Ottawa Hospital – The Globe and Mail Treatment developed at The Ottawa Hospital can halt MS progression and potentially reverse symptoms When Geneviève Bétournay developed blurry vision and pain in her hips 12 years ago, she was shocked to be diagnosed...
Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

by admin | Dec 21, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Medical News Life Sciences Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with...
Stem Cell Study Shows How Neurons from PTSD Patients React to Stress

Stem Cell Study Shows How Neurons from PTSD Patients React to Stress

by admin | Dec 20, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Genetic Engineering & Biotechnology News A study by scientists at the Icahn School of Medicine at Mount Sinai, the James J. Peters Veterans Affairs Medical Center, the Yale School of Medicine, and the New York Stem Cell Foundation Research Institute (NYSCF)...
Desperate covid long-haulers turn to costly, unproven treatments

Desperate covid long-haulers turn to costly, unproven treatments

by admin | Dec 19, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Frances Stead Sellers – The Washington Post For the burgeoning population of covid long-haulers, there is an abundance of new treatment options: Specially formulated nutraceuticals imported from India that promise to “get you life back from covid.” Pure...
Page 127 of 201« First«...102030...125126127128129...140150160...»Last »

Recent Posts

  • How TikTok can be used to recruit young stem cell donors
  • ChatGPT Health and what AI can do for a broken system
  • New treatments on the Horizon for Parkinson’s
  • CAR T-cell therapy makes ageing guts heal themselves
  • Scientists Unveil Breakthrough Method to Mass-Produce Cancer-Fighting Natural Killer Cells
  • Successful CAR T Treatment for Large B Cell Lymphoma May Depend on Circadian Rhythms
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow